Why Some of Your Transferred Fat Disappears After a BBL, and What Actually Decides How Much Survives

One of the most common sources of disappointment after a Brazilian Butt Lift is not a complication. It is the slow, quiet loss of volume over the first three to six months. Patients often describe it as the result "deflating." Clinicians describe it as graft resorption, and it is expected in every single case. Understanding why it happens, and what influences it, makes the entire recovery process far less confusing.

A BBL is a fat grafting procedure. Fat is removed from one area by liposuction, processed, and injected into the buttocks. The critical detail is that transferred fat is living tissue, not filler. Each fat cell, or adipocyte, arrives in its new location with no blood supply. For the graft to survive, the body has to rebuild that supply from scratch. Cells that do not get reconnected in time die and are gradually broken down and cleared by the immune system. That clearance is the volume loss patients see.

The survival process happens in three overlapping stages. The first is plasmatic imbibition, which begins immediately. For roughly the first 48 to 72 hours, grafted fat cells have no circulation at all. They survive by passively absorbing oxygen and nutrients from the surrounding tissue fluid, the way a sponge soaks up water. This only works over very short distances, typically a millimeter or two. This is the mechanical reason surgeons inject fat in many small, thin passes rather than in large pools. A big bolus of fat has a core that no nutrient diffusion can reach, and that core dies, sometimes forming oil cysts or firm lumps of fat necrosis.

The second stage is inosculation, starting around day three to four, when tiny blood vessels in the recipient tissue begin connecting to existing vessel remnants within the graft. The third stage is neovascularization, in which entirely new capillaries grow into the graft over the following weeks. By roughly three months, the fat that has a blood supply is stable, and the fat that never got one has largely been resorbed. This is why most surgeons refuse to judge a final result before the three month mark, and why many wait until six months before discussing touch ups.

So what determines whether a given patient lands closer to 60 percent survival or 80 percent survival? Several factors have reasonable mechanistic support. Graft handling matters. Fat is fragile. High suction pressures during harvest, aggressive processing, and long exposure to air can rupture adipocytes before they are ever injected. Dead cells cannot survive no matter how well they are placed. Injection technique matters. As noted, small aliquots spread through healthy, well vascularized tissue outperform large deposits. Current safety guidance also directs injection into the subcutaneous space rather than the muscle, which was originally a safety measure against fat embolism but also places the graft in a plane the surgeon can distribute evenly.

Patient behavior matters, within limits. The often repeated instruction to avoid direct sitting pressure for about two weeks is grounded in the imbibition and inosculation stages. Sustained pressure can compress the delicate new capillary connections and reduce perfusion to the graft during exactly the window when it is most vulnerable. That said, the popular idea that a single accidental sit will "kill the BBL" is an exaggeration. Brief pressure is not the same as hours of sustained compression. Smoking and nicotine matter a great deal. Nicotine constricts blood vessels and impairs the very neovascularization the graft depends on. This is one of the few modifiable factors with a strong, direct mechanism behind it.

Significant weight loss after surgery matters too, but for a different reason. Surviving grafted fat behaves like the fat at its donor site. If you lose weight, those cells shrink along with the rest of your fat cells. This is metabolic volume change, not graft failure, but the visual effect is similar.

There are also things that do not meaningfully change survival despite persistent marketing. Special creams, supplements marketed for "fat retention," and extreme calorie loading after surgery have no credible mechanism for improving graft revascularization. Eating enough to avoid a caloric deficit during healing is reasonable. Deliberately gaining weight to "feed the fat" mostly enlarges fat everywhere, including the donor sites the patient wanted slimmer.

The practical takeaway is this: some resorption is built into the biology, which is why experienced surgeons often place slightly more volume than the target, anticipating the loss. A result that looks somewhat larger at week two than at month four is normal, not a failure. The variables genuinely worth a patient's attention are avoiding nicotine, following pressure precautions during the first two to three weeks, maintaining a stable weight, and choosing a surgeon who can explain, specifically, how they harvest, process, and place fat. Those answers reveal more about likely retention than any before and after photo can.

Related reading: How Much Fat Actually Survives a BBL, and What Decides It.